Department of Neurosurgery, Razavi Hospital, Mashhad, Iran.
Department of Anesthesiology, Razavi Hospital, Mashhad, Iran.
World Neurosurg. 2022 Dec;168:246-257.e4. doi: 10.1016/j.wneu.2022.09.075. Epub 2022 Sep 21.
Awake craniotomy (AC) with brain mapping is a standard surgical technique for the excision of lesions located in eloquent areas. We aimed to assess the clinical challenges, patient experience, costs, and long-term outcomes of AC in a resource-limited setting.
In this cross-sectional study, electronic documents of 12 patients who underwent AC with functional brain mapping were prospectively collected from August 2017 to October 2020. Patient characteristics, surgical specifications, hospitalization period, intraoperative and postoperative events, functional outcome, patients' satisfaction, costs, and survivals were collected and analyzed.
Twelve patients with a median age of 42.5 (interquartile range, 13.5) were enrolled, of whom 8 were male (66.7%), and 9 (75%) were harboring grade 2 glioma. Of the patients, 8.34%, 33.34%, and 58.33% had partial, subtotal, and gross total excision of the tumors, respectively. The intraoperative seizure was the only complication and occurred in 2 cases (16.67%). At 1 year follow-up, none of the patients experienced any neurologic deficit. Eleven patients (91.6%) had a satisfactory opinion about reappearing in the AC. At 38 months follow-up, mortality was 8% for AC group and 25% among the historically matched controls who had surgery under general anesthesia (P = 0.27). Most costs belonged to the neurosurgery team (43%), and the overall expenses were reduced by 13% compared with a putatively well-equipped setting in our country.
In carefully selected individuals, AC with brain mapping for excision of gliomas could be a safe, effective, and affordable strategy in a resource-limited setting and can be successfully performed with satisfactory outcomes.
唤醒开颅术(AC)联合脑功能定位是切除位于功能区病变的标准手术技术。我们旨在评估资源有限环境下 AC 的临床挑战、患者体验、成本和长期结果。
在这项前瞻性的病例系列研究中,我们从 2017 年 8 月至 2020 年 10 月,共连续纳入 12 例行 AC 联合功能脑定位的患者,收集了患者的一般资料、手术细节、住院时间、术中及术后事件、功能结局、患者满意度、费用和生存情况。
共纳入 12 例患者,中位年龄 42.5 岁(四分位间距 13.5 岁),其中男性 8 例(66.7%),9 例(75%)为 2 级胶质瘤。8.34%、33.34%和 58.33%的患者肿瘤分别行部分、次全和大体全切除。仅 2 例(16.67%)患者术中发生癫痫。术后 1 年,无患者出现任何神经功能缺损。11 例(91.6%)患者对再次行 AC 持满意态度。随访 38 个月,AC 组死亡率为 8%,而在历史上匹配的全麻手术对照组中为 25%(P=0.27)。神经外科团队的费用占比最高(43%),与我国设备较好的环境相比,总费用降低了 13%。
在经过仔细选择的患者中,在资源有限的环境下,AC 联合脑功能定位切除脑胶质瘤可能是一种安全、有效且经济的策略,可获得良好的结局。